You can buy or sell ANCN and other stocks, options, and ETFs commission-free!
Anchiano Therapeutics Ltd. American Depositary Share, also called Anchiano Therapeutics, is a clinical-stage biopharmaceutical company, which engages in tin the discovery, development and commercialization of drugs for cancer-related diseases. Its products include two drugs for cancer BC-819 and BC-821. The company was founded by Avraham Hochberg in 2004 and is headquartered in Jerusalem, Israel. The listed name for ANCN is Anchiano Therapeutics Ltd. American Depositary Share.
52 Week High
52 Week Low
— per share
Expected Mar 17